Microsoft Corporation earnings face AI return scrutiny. See key Q1 tests for Azure growth, margins, and cash flow resilience.

Pacific Premier Bancorp acquisition expands Columbia Banking System's geographic reach and is expected to be mid-teens EPS ...

Ocular Therapeutix's AXPAXLI's strong Phase 3 SOL-1 results support a clear regulatory path, with NDA filing expected in Q4.

Vicor Corporation is supply-constrained rather than demand-constrained. Click here to read more on VICR stock and why it is a ...

QXO's $4B EBITDA target depends heavily on Beacon, which accounts for approximately 63% of the expected improvement. Read why ...

Buckreef continues to drive revenue generation needed to self-fund TRX Gold expansion plans. Click here to find out TRX stock ...

Avalo's positive LOTUS results now support a pivotal trial, and its monthly dosing gives it a potential differentiating ...

Phoenix Metals' $46.4M IPO proceeds provide over seven years of runway at current loss rates. Read why PHCAF stock is a Buy.

AAR Corp. faces volatility after a major MRO Holdings acquisition, shifting from bolt-on to transformative M&A. Read why AIR ...

IDEX delivers strong revenue and profit growth, with raised 2026 guidance and improving demand. Read why I reaffirm a Hold ...

Protagonist Therapeutics has evolved into a royalty-driven company with two FDA-approved drugs. Read why PTGX stock is a Buy.

President Trump said Saturday that Volkswagen's Audi subsidiary plans to build an assembly plant in Georgia that will produce ...